Ali Behbahani - 19 Sep 2025 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Issuer symbol
BDTX
Transactions as of
19 Sep 2025
Net transactions value
+$14,375
Form type
4
Filing time
22 Sep 2025, 17:58:01 UTC
Previous filing
19 Aug 2025
Next filing
06 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Behbahani Ali Director 2855 SAND HILL RD, MENLO PARK /s/ Zachary Bambach, attorney-in-fact 22 Sep 2025 0001613867

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDTX Common Stock Award $14,375 +4,291 +5.6% $3.35 81,441 19 Sep 2025 Direct F1, F2
holding BDTX Common Stock 4,448,757 19 Sep 2025 See Note 3 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 18, 2025.
F3 The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.